Korean Patent System vs. US and European Patent Systems

EN|<br>CN|<br>JPCareers

HomeIntroductionExpertsPractice AreasInsightsKorean IP SystemContact Information

Korean Patent System vs. US and European Patent Systems<br>Pine IP Firm<br>February 5, 2025

In today’s global innovation landscape, patent practitioners must often navigate multiple jurisdictions. Understanding the similarities and differences among the Korean, US, and European (EP) patent systems is critical for foreign patent attorneys and IP professionals seeking effective international protection. While Korea’s patent framework shares fundamental principles—namely novelty, inventive step, and industrial applicability—with the U.S. and Europe, there are important procedural and substantive distinctions. This overview compares key aspects of Korean IP law and practice with its U.S. and European counterparts, covering topics from filing and examination to patentability criteria and enforcement. It also offers practical insights for foreign applicants aiming to secure and defend their patents in Korea.<br>Overview of the Korean Patent System<br>Administered by the Korean Intellectual Property Office (KIPO) under the Korean Patent Act, the Korean patent system operates on a first-to-file basis, aligning with most jurisdictions worldwide and the post–America Invents Act system in the U.S. A granted Korean patent confers a 20-year exclusive right from the filing date once it is registered. To be patentable, an invention must meet the criteria of industrial applicability, novelty, and inventive step.<br>Notably, Korea excludes certain subject matter on grounds similar to Europe. For example, methods of medical treatment are not considered industrially applicable and hence are not patentable. Medical devices and pharmaceuticals, however, remain eligible. This differs from U.S. practice, where some medical methods can be patented. Korea also limits software protection unless the software-related invention demonstrates a concrete technical character or effect—an approach reminiscent of Europe’s treatment of computer-implemented inventions.<br>Korea is a party to international treaties such as the Patent Cooperation Treaty (PCT) and the TRIPS Agreement, ensuring substantial alignment with global standards. Nevertheless, local rules and definitions sometimes diverge from those in the U.S. or Europe, underscoring the importance of tailoring patent strategies to each jurisdiction.<br>Filing and Examination Procedures: Korea vs. US and EP

1. Patent Filing Requirements<br>Patent applications in Korea must ultimately be submitted in Korean, although they can initially be filed in English if followed by a Korean translation within 14 months of the earliest priority date. By contrast, the U.S. requires filings in English (or a translation upon filing), and the European Patent Office (EPO) accepts English, French, or German (or other languages with a corresponding translation). Preparing high-quality translations for Korean filings is critical to avoid discrepancies that may arise from inaccurate terminology.<br>All three jurisdictions require similar documentation—specification, claims, abstract, drawings, and priority documents where applicable. However, certain formalities, such as power of attorney requirements, may vary, so coordinating with local counsel is essential.<br>2. First-to-File and Priority<br>Korea, the U.S., and Europe all employ first-to-file systems for determining patent rights. One notable difference lies in grace periods for prior disclosures. Korea offers a one-year grace period, much like the U.S., exempting inventors’ own disclosures (or those derived from the inventor) from destroying novelty if the disclosure occurred within 12 months before the filing date. This grace period is limited in scope—it does not broadly cover third-party publications unless they resulted from unauthorized disclosures. Europe, on the other hand, generally does not provide a broad grace period. Thus, applicants should be wary of making public disclosures before filing in Europe, even if grace period provisions in Korea and the U.S. might offer temporary relief.<br>3. Request for Examination<br>A distinctive procedural feature in Korea is the need to request examination proactively within three years from the filing date. If no request is filed by then, the application lapses. This deferred examination system can be strategically beneficial, allowing applicants to delay examination costs or await market developments. In Europe, a request for examination must typically be made sooner (within six months after the publication of the search report for direct European applications), while in the U.S., examination generally begins automatically once fees are paid at filing.<br>4. Examination Process and Timelines<br>After an applicant requests examination in Korea, examiners review both formal and substantive aspects. On average, the time to grant in Korea is around two to three years—comparable to or slightly...